Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Rtnew LF Artemether & Lumefantrine Tablets
Rtnew LF Artemether & Lumefantrine Tablets is a combination of two well-established antimalarial drugs: Artemether and Lumefantrine. Artemether, a derivative of artemisinin, offers rapid action against malaria parasites, while Lumefantrine provides sustained activity to prevent relapse. This combination enhances the efficacy of treatment, reduces the risk of drug resistance, and ensures comprehensive management of malaria.
Uses of Rtnew LF Artemether & Lumefantrine Tablets
Treatment of Uncomplicated Malaria: Specifically designed to treat uncomplicated malaria caused by Plasmodium falciparum, the most dangerous strain of malaria parasite.
Rapid Symptom Relief: Provides quick relief from symptoms such as fever, chills, and sweating associated with malaria.
Prevention of Relapse: Lumefantrine helps prevent relapse by ensuring the complete clearance of malaria parasites from the bloodstream.
Effective in Areas with Drug Resistance: Useful in areas where malaria strains are resistant to other antimalarial medications.
Benefits of Rtnew LF Artemether & Lumefantrine Tablets
Synergistic Action: Combines the rapid action of Artemether with the extended activity of Lumefantrine to effectively target and eliminate malaria parasites.
Improved Efficacy: Provides a highly effective treatment regimen that reduces the risk of treatment failure and relapse.
Convenient Dosing: Typically administered as a fixed-dose combination, simplifying the dosing regimen and improving patient adherence.
Broad Spectrum: Effective against Plasmodium falciparum, the most virulent malaria species, and other malaria strains.
Reduced Risk of Resistance: The combination reduces the likelihood of developing drug-resistant strains of malaria.
Mechanism of Action of Rtnew LF Artemether & Lumefantrine Tablets
Artemether acts by forming reactive metabolites that interfere with the parasites ability to detoxify heme, a toxic byproduct of hemoglobin breakdown. This action leads to the destruction of malaria parasites within red blood cells. Lumefantrine inhibits the synthesis of nucleic acids and proteins in malaria parasites, preventing their replication and ensuring their clearance from the bloodstream.